Long-Evans Tokushima Fat (OLETF) rats spontaneously develop type 2 diabetes mellitus and Long-Evans Tokushima Otsuka (LETO) rats are non-diabetic. The relationship between type 2 diabetes mellitus and colon cancer was examined in these rats. The carcinogen 1,2-dimethylhydrazine was administered subcutaneously once weekly for 10 weeks, and the animals were killed and necropsied in week 29. All OLETF rats and 80% of the LETO rats developed cancer. The number of colon cancers per rat was significantly greater in the diabetic than in the non-diabetic rats. Although the tumours tended to be larger in diabetic rats, the difference was not statistically significant. No significant differences were observed in the depth of invasion or histological type of cancer in the two groups. Type 2 diabetes mellitus may enhance the generation and growth of colon cancer.
Introduction
In recent years, several articles [1] [2] [3] [4] [5] [6] [7] [8] [9] have suggested a relationship between diabetes mellitus and the risk of colon cancer. Most were cohort or case-control studies, and the number of experimental animal studies is limited. In the present study we induced carcinogenesis in Otsuka Long-Evans Tokushima Fat (OLETF) rats, which spontaneously develop slowly progressive type 2 diabetes mellitus, and in Long-Evans Tokushima Otsuka (LETO) rats, a non-diabetic strain originating from the same colony of Long-Evans rats as the OLETF strain. 10 The agent used in this study, 1,2dimethylhydrazine (DMH), is an effective carcinogen for the large intestine.
Materials and methods PROTOCOL
The experimental protocol was designed and performed in accordance with the Guidelines for the Management of Laboratory Animals at Juntendo University School of Medicine.
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LABORATORY CONDITIONS
At the start of the trial, male rats of each strain (OLETF and LETO; Otsuka Pharmaceutical Co., Ltd, Tokyo, Japan) were 4 weeks of age. All were housed in plastic cages in an animal room with a light cycle of 12 h light and 12 h darkness. The temperature of the room was monitored. The animals were allowed free access to water and a pellet diet (MF; Oriental Yeast Co., Ltd, Tokyo, Japan).
TREATMENT
The animals were divided into four groups in the second week: group A (no treatment) consisted of LETO rats; group B (no treatment) consisted of OLETF rats; group C (DMH treatment) consisted of LETO rats; and group D (DMH treatment) consisted of OLETF rats. The DMH (Tokyo Kasei Kogyo Co., Ltd, Tokyo, Japan) was dissolved in physiological saline and was administered by subcutaneous injection at a dose of 40 mg/kg of body weight once weekly for 10 weeks, beginning in the second week. In week 28, body weight was measured and oral glucose tolerance was tested. After at least 12 h of fasting during the night before administration, glucose was administered orally at 2 g/kg while the animals were conscious. Blood samples were collected (One Touch Ultra™; Johnson & Johnson, Milpitas, California, USA) via the tail vein before and 2 h after administration to measure the glucose concentrations. All animals were killed and necropsied in week 29. The large intestine was removed, a cut was made along the long axis, and the specimen was fixed in 10% formalin solution. The large intestinal mucosa was examined grossly and any tumours were counted, measured and categorized according to the degree of invasion. The tumours were processed as for usual pathological specimens, stained with haematoxylin and eosin, and examined histopathologically.
STATISTICAL ANALYSIS
Statistical analysis was conducted using Student's t-test or the χ 2 test (SPSS II version 3; SPSS Japan Inc., Tokyo, Japan). P-values < 0.05 were considered statistically significant.
Results
At the start of the trial, control groups A and B both consisted of 10 rats and the treatment groups C and D consisted of 15 rats. One rat from group D died of an infection in week 8 and another died of cancer in week 25, so the effective number of animals in group D was 13. The mean ambient temperature in the laboratory was 24 ± 2°C.
Body weights and plasma glucose concentrations at week 28 (1 week before the animals were killed and necropsied) are shown in Table 1 . Body weight was significantly higher in group D than in group C (P < 0.05). Plasma glucose was significantly higher in group D than in group C (P < 0.01).
No tumorigenesis was observed in groups A and B. Histopathological examination showed that 12 animals (80.0%) in group C developed cancer, the total number of tumours being 25, whereas all of the 13 surviving animals in group D developed cancer, the total number of tumours being 44. The number of tumours per rat in the group was significantly higher for group D than for group C (P < 0.01). There was a tendency for the maximum tumour diameter to be larger in group D than in group C, but the difference was not significant ( Table 2) .
The degree of differentiation and depth of invasion of the tumours are given in Tables 3  and 4 , respectively; the differences between the groups were not significant. 
Discussion
There appears to be a relationship between the incidence of colon cancer and the Westernization of the Japanese diet, and there are a number of epidemiological reports on this topic. The cohort and case-control studies described in these reports have focused on the similarity between the lifestyle and risk factors for type 2 diabetes mellitus and those for colon cancer, and have indicated a relationship between the two diseases. 1 -9 Giovannuci 11 suggested that insulin resistance is a direct risk factor for colon cancer, and in recent years attention has focused on the view that hyperinsulinaemia in type 2 diabetes mellitus is also a risk factor. 1, 4 Although experimental carcinogenesis confirms that insulin activates cell growth, 12, 13 the activity appears to be transient and to be mediated by insulin-like growth factor-I (IGF-I). By binding to the IGF-I receptor, IGF-I acts on cell growth via tyrosine kinase activity and also inhibits apoptosis. 14 In addition, IGF-I is reported to promote tumorigenesis. 14, 15 In the present study we found a significantly greater number of tumours in diabetic than in non-diabetic rats treated with a carcinogen, with a trend to greater tumour diameter in the diabetic group. There was no significant difference between the normal and diabetic groups in the histopathological type or depth of invasion of the cancers. These findings do not conflict with the results from cohort and case-control studies. Both type 2 diabetes mellitus and colon cancer are increasing. Research on the relationship between these diseases may clarify the relationship between tumorigenesis and the various factors involved in tumour growth, and may lead to the practical application of chemoprevention using growth factor inhibitors.
